EUVIMEDEUVIMED entdecken
Multizentrische Studie

First‐trimester prediction of preterm pre‐eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth

Kypros H Nicolaides iD, Argyro Syngelaki, Liona C Poon, Daniel L Rolnik, Min Yi Tan, Alan Wright, David Wright

BJOG: An International Journal of Obstetrics & Gynaecology · 2024

DOI: 10.1111/1471-0528.17673 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Kypros H Nicolaides und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fetal Medicine Research Institute, King's College Hospital, London, UK. Hauptthemen laut MEDLINE: Pre-Eclampsia, Premature Birth. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: European Union 7th Framework Programme, Fetal Medicine Foundation, National Institute for Health Research Efficacy and Mechanism Evaluation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To report the predictive performance for preterm birth (PTB) of the Fetal Medicine Foundation (FMF) triple test and National Institute for health and Care Excellence (NICE) guidelines used to screen for pre‐eclampsia and examine the impact of aspirin in the prevention of PTB.

Design

Secondary analysis of data from the SPREE study and the ASPRE trial.

Setting

Multicentre studies. Population In SPREE, women with singleton pregnancies had screening for preterm pre‐eclampsia at 11–13 weeks of gestation by the FMF method and NICE guidelines. There were 16 451 pregnancies that resulted in delivery at ≥24 weeks of gestation and these data were used to derive the predictive performance for PTB of the two methods of screening. The results from the ASPRE trial were used to examine the effect of aspirin in the prevention of PTB in the population from SPREE.

Methods

Comparison of performance of FMF method and NICE guidelines for pre‐eclampsia in the prediction of PTB and use of aspirin in prevention of PTB. Main outcome measure Spontaneous PTB (sPTB), iatrogenic PTB for pre‐eclampsia (iPTB‐PE) and iatrogenic PTB for reasons other than pre‐eclampsia (iPTB‐noPE).

Results

Estimated incidence rates of sPTB, iPTB‐PE and iPTB‐noPE were 3.4%, 0.8% and 1.6%, respectively. The corresponding detection rates were 17%, 82% and 25% for the triple test and 12%, 39% and 19% for NICE guidelines, using the same overall screen positive rate of 10.2%. The estimated proportions prevented by aspirin were 14%, 65% and 0%, respectively.

Conclusion

Prediction of sPTB and iPTB‐noPE by the triple test was poor and poorer by the NICE guidelines. Neither sPTB nor iPTB‐noPE was reduced substantially by aspirin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaPremature BirthFemaleHumansInfant, NewbornPregnancyAspirinBiomarkersIatrogenic DiseasePlacenta Growth FactorPregnancy Trimester, FirstUterine ArteryClinical Trials as Topic

Stichwörter der Autor:innen

ASPRE trialNICE guidelinesSPREE studyaspirincompeting risks modelmean arterial pressureplacental growth factorpre-eclampsiapreterm birthuterine artery Doppler

Substanzen

AspirinBiomarkersPlacenta Growth Factor

Autor:innen und Institutionen

  • Fetal Medicine Research Institute, King's College Hospital, London, UK.
  • Institute of Women and Children's Health, School of Life Course and Population Sciences, King's College London, London, UK.
  • Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Obstetrics and Gynaecology, School of Clinical Sciences, Monash University, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, St Mary's Hospital, London, UK.
  • Institute of Health Research, University of Exeter, Exeter, UK.

ORCID-Profile: Kypros H Nicolaides

Förderung

  • European Union 7th Framework Programme
  • Fetal Medicine Foundation
  • National Institute for Health Research Efficacy and Mechanism Evaluation
  • Revvity
  • Thermo Fisher Scientific
  • Seventh Framework Programme

Zitieren

APA

Nicolaides, K. H., Syngelaki, A., Poon, L. C., Rolnik, D. L., Tan, M. Y., Wright, A., & Wright, D. (2024). First‐trimester prediction of preterm pre‐eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17673

Vancouver

Nicolaides KH, Syngelaki A, Poon LC, Rolnik DL, Tan MY, Wright A, et al. First‐trimester prediction of preterm pre‐eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17673

BibTeX
@article{Nicolaides2024,
  author = {Nicolaides, Kypros H and Syngelaki, Argyro and Poon, Liona C and Rolnik, Daniel L and Tan, Min Yi and Wright, Alan and Wright, David},
  title = {First‐trimester prediction of preterm pre‐eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth},
  journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
  year = {2024},
  doi = {10.1111/1471-0528.17673}
}
Kostenlos starten →